975 related articles for article (PubMed ID: 20376313)
1. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease.
Spilman P; Podlutskaya N; Hart MJ; Debnath J; Gorostiza O; Bredesen D; Richardson A; Strong R; Galvan V
PLoS One; 2010 Apr; 5(4):e9979. PubMed ID: 20376313
[TBL] [Abstract][Full Text] [Related]
2. Over-expression of heat shock factor 1 phenocopies the effect of chronic inhibition of TOR by rapamycin and is sufficient to ameliorate Alzheimer's-like deficits in mice modeling the disease.
Pierce A; Podlutskaya N; Halloran JJ; Hussong SA; Lin PY; Burbank R; Hart MJ; Galvan V
J Neurochem; 2013 Mar; 124(6):880-93. PubMed ID: 23121022
[TBL] [Abstract][Full Text] [Related]
3. [Effect of moxibustion on autophagy in mice with Alzheimer's disease based on mTOR/p70S6K signaling pathway].
Wu YY; Song XG; Zhu CF; Cai SC; Ge X; Wang L; Jia YM
Zhongguo Zhen Jiu; 2022 Sep; 42(9):1011-6. PubMed ID: 36075597
[TBL] [Abstract][Full Text] [Related]
4. Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the
Shi Q; Chang C; Saliba A; Bhat MA
J Neurosci; 2022 Jul; 42(27):5294-5313. PubMed ID: 35672148
[TBL] [Abstract][Full Text] [Related]
5. mTOR Attenuation with Rapamycin Reverses Neurovascular Uncoupling and Memory Deficits in Mice Modeling Alzheimer's Disease.
Van Skike CE; Hussong SA; Hernandez SF; Banh AQ; DeRosa N; Galvan V
J Neurosci; 2021 May; 41(19):4305-4320. PubMed ID: 33888602
[TBL] [Abstract][Full Text] [Related]
6. Mammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer's disease?
Cai Z; Zhao B; Li K; Zhang L; Li C; Quazi SH; Tan Y
J Neurosci Res; 2012 Jun; 90(6):1105-18. PubMed ID: 22344941
[TBL] [Abstract][Full Text] [Related]
7. [Moxibustion at acpoints of governor vessel on regulating PI3K/Akt/mTOR signaling pathway and enhancing autophagy process in APP/PS1 double-transgenic Alzheimer's disease mice].
Zhang LD; Han W; Zhu CF; Song XG; Cheng H; Yang K; Qin XF; Zhang JY; Gui L
Zhongguo Zhen Jiu; 2019 Dec; 39(12):1313-8. PubMed ID: 31820607
[TBL] [Abstract][Full Text] [Related]
8. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments.
Caccamo A; Majumder S; Richardson A; Strong R; Oddo S
J Biol Chem; 2010 Apr; 285(17):13107-20. PubMed ID: 20178983
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment.
Van Skike CE; Jahrling JB; Olson AB; Sayre NL; Hussong SA; Ungvari Z; Lechleiter JD; Galvan V
Am J Physiol Heart Circ Physiol; 2018 Apr; 314(4):H693-H703. PubMed ID: 29351469
[TBL] [Abstract][Full Text] [Related]
10. Combined induction of mTOR-dependent and mTOR-independent pathways of autophagy activation as an experimental therapy for Alzheimer's disease-like pathology in a mouse model.
Pupyshev AB; Belichenko VM; Tenditnik MV; Bashirzade AA; Dubrovina NI; Ovsyukova MV; Akopyan AA; Fedoseeva LA; Korolenko TA; Amstislavskaya TG; Tikhonova MA
Pharmacol Biochem Behav; 2022 Jun; 217():173406. PubMed ID: 35609863
[TBL] [Abstract][Full Text] [Related]
11. Alteration of the Wnt/GSK3β/β‑catenin signalling pathway by rapamycin ameliorates pathology in an Alzheimer's disease model.
Chen J; Long Z; Li Y; Luo M; Luo S; He G
Int J Mol Med; 2019 Jul; 44(1):313-323. PubMed ID: 31115485
[TBL] [Abstract][Full Text] [Related]
12. Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer's disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature.
Caccamo A; De Pinto V; Messina A; Branca C; Oddo S
J Neurosci; 2014 Jun; 34(23):7988-98. PubMed ID: 24899720
[TBL] [Abstract][Full Text] [Related]
13. How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story.
Richardson A; Galvan V; Lin AL; Oddo S
Exp Gerontol; 2015 Aug; 68():51-8. PubMed ID: 25481271
[TBL] [Abstract][Full Text] [Related]
14. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
[TBL] [Abstract][Full Text] [Related]
15. Transferrin decorated-nanostructured lipid carriers (NLCs) are a promising delivery system for rapamycin in Alzheimer's disease: An in vivo study.
Khonsari F; Heydari M; Sharifzadeh M; Valizadeh H; Dinarvand R; Atyabi F
Biomater Adv; 2022 Jun; 137():212827. PubMed ID: 35929260
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin Ameliorates Cognitive Impairments and Alzheimer's Disease-Like Pathology with Restoring Mitochondrial Abnormality in the Hippocampus of Streptozotocin-Induced Diabetic Mice.
Ding Y; Liu H; Cen M; Tao Y; Lai C; Tang Z
Neurochem Res; 2021 Feb; 46(2):265-275. PubMed ID: 33140268
[TBL] [Abstract][Full Text] [Related]
17. Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease.
Cassano T; Magini A; Giovagnoli S; Polchi A; Calcagnini S; Pace L; Lavecchia MA; Scuderi C; Bronzuoli MR; Ruggeri L; Gentileschi MP; Romano A; Gaetani S; De Marco F; Emiliani C; Dolcetta D
Exp Neurol; 2019 Jan; 311():88-105. PubMed ID: 30243986
[TBL] [Abstract][Full Text] [Related]
18. [Effect of mammalian target of rapamycin on cognitive dysfunction of Alzheimer's Disease via regulating Homer3].
Huang YQ; Liu XG; Zhang L; Yu Y; Xue J; Sun JL
Zhonghua Yi Xue Za Zhi; 2020 May; 100(17):1336-1340. PubMed ID: 32375443
[No Abstract] [Full Text] [Related]
19. Geniposide-mediated protection against amyloid deposition and behavioral impairment correlates with downregulation of mTOR signaling and enhanced autophagy in a mouse model of Alzheimer's disease.
Zhang Z; Wang X; Zhang D; Liu Y; Li L
Aging (Albany NY); 2019 Jan; 11(2):536-548. PubMed ID: 30684442
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin and mTOR inhibitors probably have therapeutic effects for post-operative cognitive dysfunction.
Yang C; Zhu B; Shen J; Hu T; Li Z; Hong T
Med Hypotheses; 2013 Sep; 81(3):487-8. PubMed ID: 23850396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
